glp 1 receptor agonists mechanism of action GLP1 Agonists—Effects beyond Obesity and Diabetes Trends in the Development of
Description
The US Food & Drug Administration has approved only some GLP-1 drugs for weight loss and long-term weight management and only when certain conditions are met
they did not find that the drugs caused tumor growth
Thus, target validation was achieved in which JWU-A021 was established to be a TRPA1 channel activator
Current Molecular Pharmacology
